Anebulo Pharmaceuticals
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Anebulo Pharmaceuticals's balance sheet done over the years? Its assets were worth $4,073,114 last year, which is less than in the previous period. 6% of Anebulo Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $260,583, which means an decrease by -76% compared compared to last year.

Debt to Assets

Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB): Debt to assets
2020 3028480 3.19M 105.65%
2021 21653491 241.63K 1.12%
2022 15579431 512.53K 3.29%
2023 11670151 1.06M 9.16%
2024 4073114 260.58K 6.4%

ANEB Balance Sheet (2020 – 2024)

2024 2023 2022 2021 2020
Assets
Current assets:
Cash and cash equivalents
3.09M11.24M14.54M19.98M3.02M
Short term investments
00000
Net receivables
00003.5K
Inventory
0000-3
Other current assets
413.79K422.74K1.03M1.66M3
Total current assets
3.50M11.24M14.54M19.98M3.02M
Non-current assets:
Property, Plant and Equipment
00000
Goodwill
00000
Intangible assets
00000
Long term investments
00000
Other non-current assets
565.12K0000
Total non-current assets
565.12K01.03M1.66M0
Total assets
4.07M11.67M15.57M21.65M3.02M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
00000
Short term debt
0000201.28K
Total current liabilities
260.58K534.54K512.53K241.63K223.86K
Non-current liabilities:
Long term debt
00000
Deferred tax
00000
Other non-current liabilities
000131.58K0
Total non-current liabilities
0534.25K380.82K131.58K2.97M
Total liabilities
260.58K1.06M512.53K241.63K3.19M
Data sourceData sourceData source